Healthcare Realty Trust Incorporated (HR) financial statements (2021 and earlier)
Company profile
| Business Address |
3310 WEST END AVE NASHVILLE, TN 37203 |
| State of Incorp. | MD |
| Fiscal Year End | December 31 |
| SIC | 6798 - Real Estate Investment Trusts (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1 | 12 | 8 | 11 | 8 | 10 | 7 | ||
| Cash and cash equivalents | 1 | 12 | 8 | 11 | 8 | 10 | 7 | ||
| Receivables | 13 | ||||||||
| Total current assets: | 14 | 12 | 8 | 11 | 8 | 10 | 7 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | 13 | ✕ | ✕ | ✕ | |||||
| Operating lease, right-of-use asset | 126 | ✕ | ✕ | ✕ | |||||
| Inventory, real estate | 25 | 25 | |||||||
| Property, plant and equipment | 290 | 268 | 248 | 230 | 230 | 217 | 215 | ||
| Long-term investments and receivables | 8 | 9 | |||||||
| Long-term investments | 8 | 9 | |||||||
| Intangible assets, net (including goodwill) | 7 | 22 | |||||||
| Goodwill | 4 | 4 | |||||||
| Intangible assets, net (excluding goodwill) | 4 | 19 | |||||||
| Total noncurrent assets: | 468 | 268 | 248 | 230 | 285 | 217 | 215 | ||
| Other undisclosed assets | 3,082 | 3,212 | 3,173 | 3,121 | 2,898 | 2,974 | 2,993 | ||
| TOTAL ASSETS: | 3,564 | 3,491 | 3,429 | 3,363 | 3,191 | 3,201 | 3,215 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Noncurrent Liabilities | |||||||||
| Other undisclosed liabilities | 1,664 | 1,686 | 1,659 | 1,557 | 1,475 | 1,461 | 1,447 | ||
| Total liabilities: | 1,664 | 1,686 | 1,659 | 1,557 | 1,475 | 1,461 | 1,447 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 1,900 | 1,805 | 1,769 | 1,806 | 1,717 | 1,740 | 1,768 | ||
| Common stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Additional paid in capital | 3,485 | 3,380 | 3,305 | 3,303 | 3,180 | 3,181 | 3,179 | ||
| Accumulated other comprehensive income (loss) | (6) | (8) | (6) | (2) | (1) | 0 | 0 | ||
| Other undisclosed stockholders' equity attributable to parent | (1,580) | (1,567) | (1,531) | (1,497) | (1,464) | (1,443) | (1,412) | ||
| Total stockholders' equity: | 1,900 | 1,805 | 1,769 | 1,806 | 1,717 | 1,740 | 1,768 | ||
| TOTAL LIABILITIES AND EQUITY: | 3,564 | 3,491 | 3,429 | 3,363 | 3,191 | 3,201 | 3,215 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 122 | 120 | 116 | 113 | 113 | 113 | 112 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 110 | |
| Operating leases, income statement, lease revenue | ✕ | 118 | 114 | 111 | 111 | 111 | ||
| Cost of revenue | (0) | (0) | ||||||
| Provision for loan, lease, and other losses | (0) | |||||||
| Financial services costs | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | (0) | |
| Gross profit: | 122 | 120 | 116 | 113 | 113 | 113 | 112 | |
| Operating expenses | (101) | (103) | (96) | (94) | (94) | (95) | (90) | |
| Operating income: | 21 | 17 | 20 | 18 | 19 | 19 | 21 | |
| Nonoperating income (expense) | 6 | (14) | (15) | (14) | (3) | (12) | 17 | |
| Interest and debt expense | (14) | (14) | (14) | (14) | (14) | (13) | (13) | |
| Income (loss) from continuing operations before equity method investments, income taxes: | 13 | (12) | (9) | (9) | 3 | (7) | 25 | |
| Income (loss) from equity method investments | (0) | 0 | ||||||
| Income (loss) from continuing operations before income taxes: | 13 | (12) | (9) | (9) | 3 | (7) | 25 | |
| Other undisclosed income from continuing operations | 55 | 53 | ||||||
| Net income (loss): | 69 | (12) | (9) | (9) | 56 | (7) | 25 | |
| Other undisclosed net income (loss) attributable to parent | (42) | 14 | 14 | 14 | (39) | 13 | 13 | |
| Net income available to common stockholders, diluted: | 27 | 3 | 4 | 5 | 16 | 7 | 38 | |
Comprehensive Income ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 69 | (12) | (9) | (9) | 56 | (7) | 25 | |
| Other comprehensive income (loss) | 2 | (2) | (5) | (1) | ||||
| Other undisclosed comprehensive income | 0 | |||||||
| Comprehensive income (loss): | 71 | (14) | (14) | (9) | 56 | (7) | 25 | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (42) | 14 | 14 | 14 | (41) | 14 | 14 | |
| Comprehensive income (loss), net of tax, attributable to parent: | 30 | 0 | (0) | 4 | 15 | 7 | 38 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.